The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
10,876
Sort by:
Hutchinson-Gilford Progeria Syndrome Market - 2024-2031
US$ 3,400.00
The Hutchinson-Gilford Progeria Syndrome Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresigh...
April 2025
62 pages
Latin America Pain Management Drugs Market - 2025-2033
US$ 2,499.00
Latin America Pain Management Drugs Market reached US$ 4,069.52 million in 2024 and is expected to reach US$ 6,576.78 million by 2033, growing with a CAGR of 5.60% during the forecast period 2026-2033...
April 2025
61 pages
North America Pain Management Market - 2025-2033
US$ 2,499.00
North America Pain Management Market reached US$ 25.85 billion in 2024 and is expected to reach US$ 46.87 billion by 2033, growing with a CAGR of 6.90% during the forecast period 2026-2033. The North...
April 2025
55 pages
Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic Area (Diabetes, Gastroenterology, Genetic Disorder), Formulation (Tablet, Capsule) - Global Forecast to 2030
US$ 2,970.00
The global market for oral proteins and peptides is projected to reach USD 24.00 billion by 2030 from USD 8.85 billion in 2025, at a CAGR of 22.1% during the forecast period from 2025 to 2030. The inc...
April 2025
326 pages
Prader-Willi Syndrome Market - 2025-2033
US$ 3,400.00
Prader-Willi Syndrome Marketis is growing with a CAGR of 6.00% during the forecast period 2026-2035. The Prader-Willi Syndrome Market emerges as a key focus in DataM Intelligence latest in-depth analy...
April 2025
47 pages
Europe Pain Management Drugs Market - 2025-2033
US$ 2,499.00
Europe Pain Management Drugs Market reached US$ 17.13 billion in 2024 and is expected to reach US$ 33.77 billion by 2033, growing with a CAGR of 7.90% during the forecast period 2026-2033. The Europe...
April 2025
54 pages
Compounding Chemotherapy Market By Dose type (Chemotherapeutic, Non-chemotherapeutic), By Compounding Type (Pharmaceutical Ingredient Alteration, Currently Unavailable Pharmaceutical Manufacturing, Pharmaceutical Dosage Alteration), By Delivery method (Gravimetric automated Compounding Device, Volumetric Automated Compounding Device), By Sterility (Sterile, Non-sterile), By Technology (With Robotic arm, Without Robotic Arm): Global Opportunity Analysis and Industry Forecast, 2025-2034
US$ 2,655.00
The compounding chemotherapy market was valued at $5,267.03 million in 2024 and is estimated to reach $9,826.7 million by 2034, exhibiting a CAGR of 6.4% from 2025 to 2034.Compounding chemotherapy inv...
April 2025
364 pages
Dermatophytic Onychomycosis Treatment Market Forecasts to 2032 – Global Analysis By Product Type (Tablets, Nail Paints/Lacquers, Ointments & Creams, Laser Therapy Devices, Photodynamic Therapy (PDT) Solutions, and Other Product Types), Route of Administration, Treatment, Distribution Channel and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Dermatophytic Onychomycosis Treatment Market is accounted for $5.7 billion in 2025 and is expected to reach $10.8 billion by 2032 growing at a CAGR of 9.5% dur...
April 2025
150 pages
Gaucher Disease Pipeline Insights 2025 2026
US$ 2,999.00
The Gaucher Disease Pipeline Insights 2025 was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includi...
March 2025
210 pages
IgA Nephropathy Drugs Market - 2024-2031
US$ 3,400.00
IgA Nephropathy Drugs Marketis is growing with a CAGR of 18.10% during the forecast period 2026-2035. The IgA Nephropathy Drugs Market emerges as a key focus in DataM Intelligence latest in-depth anal...
March 2025
47 pages
Global Gaucher Disease Treatment Market - 2025-2033
US$ 3,400.00
Global Gaucher Disease Treatment Marketis is growing with a CAGR of 2.90% during the forecast period 2026-2035. The Global Gaucher Disease Treatment Market emerges as a key focus in DataM Intelligence...
March 2025
58 pages
Hurler Syndrome Treatment Market - 2025-2033
US$ 3,400.00
Hurler Syndrome Treatment Market reached US$ 377.65 million in 2024 and is expected to reach US$ 529.34 million by 2033, growing with a CAGR of 3.90% during the forecast period 2026-2033. The Hurler S...
March 2025
51 pages
Hydronephrosis Market - 2024-2031
US$ 3,400.00
Hydronephrosis Marketis is growing with a CAGR of 9.50% during the forecast period 2026-2035. The Hydronephrosis Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where sea...
March 2025
40 pages
Alpha Thalassemia Market - 2024-2031
US$ 3,400.00
Alpha Thalassemia Market reached US$ 1.1 billion in 2022 and is expected to reach US$ 1.9 billion by 2031, growing with a CAGR of 7.40% during the forecast period 2026-2031. The Alpha Thalassemia Mark...
March 2025
43 pages
Antimicrobial Therapeutics Market Size, Share, and Analysis, By Drug Class (Antibacterial, Antivirals, Antifungal, and Antiparasitic), By Route of Administration (Oral, Tropic, Injectable, and Others), By Disease Indication (Respiratory Infections, Urinary Tract Infections, Skin and Soft Tissue Infections, Sexually Transmitted Infections, Gastrointestinal Infections, Central Nervous System Infections, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Antimicrobial Therapeutics Market Size, Share, and Analysis, By Drug Class (Antibacterial, Antivirals, Antifungal, and Antiparasitic), By Route of Administration (Oral, Tropic, Injectable, and Others)...
March 2025
406 pages
Heparin Market Size, Share, Trends and Forecast by Product, Source, Mode of Administration, Application, End-User, Distribution Channel, and Region 2025-2033
US$ 2,999.00
The global heparin market size was valued at USD 7.46 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 9.02 Billion by 2033, exhibiting a CAGR of 2.12% during 2025-2033....
March 2025
145 pages
Albendazole Anthelmintic Drug Market - 2024-2031
US$ 3,400.00
Albendazole Anthelmintic Drug Marketis is growing with a CAGR of 6.50% during the forecast period 2026-2035. The Albendazole Anthelmintic Drug Market emerges as a key focus in DataM Intelligence lates...
February 2025
55 pages
Hypovolemic Shock Market - 2024-2031
US$ 3,400.00
The Hypovolemic Shock Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpara...
February 2025
43 pages
Hypereosinophilic Syndrome Market - 2024-2031
US$ 3,400.00
Hypereosinophilic Syndrome Marketis is growing with a CAGR of 8.60% during the forecast period 2026-2035. The Hypereosinophilic Syndrome Market emerges as a key focus in DataM Intelligence latest in-d...
February 2025
52 pages
Immune Checkpoint Inhibitors Market - 2024-2031
US$ 3,400.00
Immune Checkpoint Inhibitors Market reached US$ 40.1 billion in 2023 and is expected to reach US$ 156.6 billion by 2031, growing with a CAGR of 16.50% during the forecast period 2026-2031. The Immune...
February 2025
54 pages
Hormonal Contraceptive Market By Product (Oral contraceptive pills, Injectable birth control, Emergency contraceptive pills, Vaginal rings, Transdermal patches, IUS and Implants), By Hormone (Progestin only contraceptive, Combined hormonal contraceptive), By Age Group (15 to 24 years, 25 to 34 years, 35 to 44 years, Above 44 years), By End User (Hospitals, Household, Clinics): Global Opportunity Analysis and Industry Forecast, 2024-2035
US$ 2,655.00
... use of contraceptives hamper the market growth. The global hormonal contraceptive market is segmented on the basis of product, hormone, age group, end user, and geography. Based on product, the market is classified ...
February 2025
348 pages
Aspirin Drugs Market By Dosage Form (Tablets, Capsules, Others), By Application (Pain Relief, Cardiovascular Disease Prevention, Anti-inflammatory Uses, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2024-2035
US$ 2,655.00
The aspirin drugs market was valued for $1.3 billion in 2023 and is estimated to reach $1.8 billion by 2035, exhibiting a CAGR of 2.7% from 2024 to 2035. Aspirin, also known as acetylsalicylic acid, i...
February 2025
264 pages
Food Allergy Treatment Market Forecasts to 2030 – Global Analysis By Allergen Type (Dairy Products, Poultry Products, Tree Nuts, Peanuts, Shellfish, Wheat, Soys and Other Allergen Types), Drug Type, Route of Administration, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Food Allergy Treatment Market is accounted for $7.13 billion in 2024 and is expected to reach $12.81 billion by 2030 growing at a CAGR of 10.27% during the for...
February 2025
150 pages
Genital Dysfunction Drugs Market - 2024-2031
US$ 3,400.00
Genital Dysfunction Drugs Market reached US$ 4.15 billion in 2023 and is expected to reach US$ 7.16 billion by 2031, growing with a CAGR of 7.00% during the forecast period 2026-2031. The Genital Dysf...
January 2025
51 pages
Gluten Intolerance Treatment Market - 2025-2032
US$ 3,400.00
Gluten Intolerance Treatment Market reached US$ 6.63 billion in 2024 and is expected to reach US$ 16.18 billion by 2032, growing with a CAGR of 11.80% during the forecast period 2026-2032. The Gluten...
January 2025
54 pages
Polycythemia Market - 2025-2033
US$ 3,400.00
Polycythemia Market reached US$ 5.89 billion in 2024 and is expected to reach US$ 12.41 billion by 2033, growing with a CAGR of 6.70% during the forecast period 2026-2033. The Polycythemia Market emer...
January 2025
38 pages
Iron Deficiency Anemia Market - 2025-2032
US$ 3,400.00
Iron Deficiency Anemia Market reached US$ 4.39 billion in 2024 and is expected to reach US$ 7.33 billion by 2032, growing with a CAGR of 6.80% during the forecast period 2026-2032. The Iron Deficiency...
January 2025
48 pages
Global Tumor Necrosis Factor Inhibitor Drugs Market Size Study by Product (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars), by Application (Rheumatoid Arthritis, Psoriasis, Ulcerative Colitis, Crohn’s Disease, and Others), by Sales Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), and Regional Forecasts 2022-2032
US$ 3,750.00
TNF inhibitors are pivotal in treating autoimmune and inflammatory conditions, including rheumatoid arthritis, psoriasis, and Crohn’s disease, by targeting and inhibiting the action of tumor necrosis...
January 2025
285 pages
Global Artificial Intelligence in Drug Discovery Market Size Study, by Application (Drug Optimization and Repurposing, Preclinical Testing, Others), by Therapeutic Area (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Others), and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Artificial Intelligence (AI) in Drug Discovery Market was valued at approximately USD 1.6 billion in 2023 and is projected to expand at a robust CAGR of 29.7% during the forecast period 202...
January 2025
285 pages
Global Post-traumatic Stress Disorder Treatment Market Size study, by Drug Class (Antidepressants, Anti-anxiety, Antipsychotics, Other Drug Class), by Demographics (Adult, Children, Geriatric), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Other Pharmacies) and Regional Forecasts 2022-2032
US$ 3,750.00
The global post-traumatic stress disorder (PTSD) treatment market was valued at USD 2.14 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.08% over the forecast p...
January 2025
285 pages
Chronic Inflammation Treatment Market - 2024-2031
US$ 3,400.00
The Chronic Inflammation Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to d...
January 2025
56 pages
Global Age-related Macular Degeneration (AMD) Drugs Market Size Study, by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), by Molecule (Ranibizumab, Aflibercept, Faricimab), by Approval Type (Biologic, Biosimilar), by Type of AMD, and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Age-related Macular Degeneration (AMD) Drugs Market is currently valued at approximately USD 9.45 billion in 2023 and is forecasted to grow at an impressive CAGR of 10.70% over the forecast...
January 2025
285 pages
OTC Drugs, Medical Devices and Diagnostics: Global Markets
US$ 4,650.00
Report : The current report provides detailed information and estimates through 2029 and market shares for key market players. It details the market size of OTC drugs, medical devices, and diagnostics...
January 2025
139 pages
